CAMP and systemic lupus erythematosus: Enhanced LL-37 expression has also been implicated in the pathophysiology of several other diseases like breast cancer, atherosclerosis, Alzheimer's disease, and lupus (5, 10, 11, 12), thus suggesting that the autoinflammatory activity of LL-37 may be important to a wide range of human diseases.